Published in Leuk Lymphoma on December 06, 2010
Activation-induced Cytidine Deaminase in B Cell Immunity and Cancers. Immune Netw (2012) 0.85
Attenuating homologous recombination stimulates an AID-induced antileukemic effect. J Exp Med (2013) 0.85
AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells. Eur J Immunol (2014) 0.84
Leukocytoclastic vasculitis due to thalidomide in multiple myeloma. Jpn J Clin Oncol (2007) 0.90
Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis. Turk J Haematol (2015) 0.88
Coexistence of chronic neutrophilic leukemia with multiple myeloma. Leuk Lymphoma (2002) 0.86
Efficacy of a modified mandibular advancement device for a totally edentulous patient with severe obstructive sleep apnea. Sleep Breath (2009) 0.84
Polymorphisms of the angiotensin-converting enzyme and angiotensinogen gene in patients with atrial fibrillation. J Renin Angiotensin Aldosterone Syst (2011) 0.83
The association between factor XIII Val34Leu polymorphism and early myocardial infarction. Circ J (2006) 0.83
Investigation of Arg399Gln and Arg194Trp polymorphisms of the XRCC1 (x-ray cross-complementing group 1) gene and its correlation to sister chromatid exchange frequency in patients with chronic lymphocytic leukemia. Genet Test Mol Biomarkers (2011) 0.83
Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism. Clin Appl Thromb Hemost (2007) 0.82
The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case report. J Med Case Rep (2012) 0.79
Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm. Ann Hematol (2011) 0.79
Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study. Stroke (2005) 0.78
The impact of platelet membrane glycoprotein Ib alpha and Ia/IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome. Thromb Res (2011) 0.77
Thrombotic risk in patients submitted to splenectomy for systemic lupus erythematosus and antiphospholipid antibody syndrome-related thrombocytopenia. Eur J Intern Med (2004) 0.77
Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor. Am J Hematol (2007) 0.77
Comparison of KRAS mutation tests in colorectal cancer patients. Genet Test Mol Biomarkers (2011) 0.77
Analysis of p53 tumor suppressor pathway genes in chronic lymphocytic leukemia. DNA Cell Biol (2011) 0.77
Real-Time PCR analysis of af4 and dek genes expression in acute promyelocytic leukemia t (15;17) patients. Exp Mol Med (2004) 0.77
Analysis of activation-induced cytidine deaminase mRNA levels in patients with chronic lymphocytic leukemia with different cytogenetic status. Leuk Lymphoma (2013) 0.76
The association of P-selectin glycoprotein ligand-1 VNTR polymorphisms with coronary stent restenosis. J Thromb Thrombolysis (2007) 0.76
Genotoxicity and sister chromatid exchange in patients with myelodysplastic disorders. Cancer Genet Cytogenet (2005) 0.76
Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients. Med Oncol (2011) 0.76
Evaluation of Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 Expression Levels in Patients with Chronic Lymphocytic Leukemia. Turk J Haematol (2016) 0.75
Cytokine Contents in Chronic Lymphocytic Leukemia: Association with ZAP70 Expression. Turk J Haematol (2015) 0.75
[Psychogenic purpura with hematuria and sexual pain disorder: a case report]. Turk Psikiyatri Derg (2010) 0.75
A rare manifestation of tuberous xanthomas. J Gen Intern Med (2014) 0.75
Osteoporosis and osteopathy markers in patients with mastocytosis. Turk J Haematol (2015) 0.75
The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis. J Thromb Thrombolysis (2012) 0.75
Endocan: A Novel Marker of Endothelial Dysfunction in C1-Inhibitor-Deficient Hereditary Angioedema. Int Arch Allergy Immunol (2017) 0.75
Turkish population data on the factor XIII Val34Leu,glycoprotein (GP)Ibalpha Kozak and P-selectin glycoprotein ligand 1 (PSGL-1) loci. Cell Biochem Funct (2004) 0.75
Comparison of the cytogenetic and molecular analyses in the assessment of imatinib response in chronic myelocytic leukemia. Genet Test Mol Biomarkers (2009) 0.75
Angiotensin-converting enzyme gene polymorphism in arrhythmogenic right ventricular dysplasia: is DD genotype helpful in predicting syncope risk? J Renin Angiotensin Aldosterone Syst (2008) 0.75
Isolated renal intravascular lymphoma: a case report and review of the literature. Ren Fail (2014) 0.75
A different approach to telomere analysis with ddPRINS in chronic lymphocytic leukemia. Eur J Med Genet (2005) 0.75
Quantification of All-Trans-Retinoic Acid (ATRA) Dependent Expression of CXCR4 Gene in Acute Promyelocytic Leukaemia. Turk J Haematol (2003) 0.75
Could Anticoagulation or Antiaggregation Treatment Be Ceased in Patients With Primary Antiphospholipid Syndrome When Antiphospholipid Antibodies Become Persistently Negative? J Clin Rheumatol (2017) 0.75
Real-time PCR analysis of the apoptosis related genes in ATRA treated APL t(15;17) patients. Exp Mol Med (2003) 0.75